Petra Temming
Essen, NW 45147, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Corrigendum to "Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines" [Exp. Cell Res. 375 (2019) 92-99].
Journal: Experimental cell research
Published: March 29, 2023
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.
Journal: Ophthalmology
Published: December 18, 2019
Retinoblastoma with late metastatic spread-a case report.
Journal: Pediatric blood & cancer
Published: December 20, 2018
Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
Journal: Pediatric blood & cancer
Published: November 20, 2018
Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Journal: Experimental cell research
Published: August 07, 2018
DNA methylation-based classification of central nervous system tumours.
Journal: Nature
Published: May 05, 2017
The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors.
Journal: Deutsches Arzteblatt international
Published: January 05, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Journal: American journal of medical genetics. Part A
Published: October 12, 2016
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 07, 2016
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Journal: Clinical & experimental ophthalmology
Published: June 15, 2016
Last Updated: 09/26/2026